Jeff Slezak to Risk Assessment
This is a "connection" page, showing publications Jeff Slezak has written about Risk Assessment.
Connection Strength
0.366
-
Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
Score: 0.131
-
The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018 04; 188:111-122.
Score: 0.109
-
Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. J Urol. 2021 May; 205(5):1387-1393.
Score: 0.033
-
Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population. BJU Int. 2017 10; 120(4):520-529.
Score: 0.026
-
Evaluation of microscopic hematuria and risk of urologic cancer in female patients. Am J Obstet Gynecol. 2017 Feb; 216(2):146.e1-146.e7.
Score: 0.025
-
The effect of urologist experience on choosing active surveillance for prostate cancer. World J Urol. 2015 Nov; 33(11):1701-6.
Score: 0.022
-
The Kaiser Permanente experience with ultrasound-guided percutaneous endovascular abdominal aortic aneurysm repair. Ann Vasc Surg. 2012 Oct; 26(7):906-12.
Score: 0.018